Please Subscribe to get a daily link to Pat's blog via email

Subscribe!

Your privacy is important to us. We will never spam you and keep your personal data secure.

Millennium Pharmaceuticals

Home/Tag:Millennium Pharmaceuticals
10 08, 2014

Velcade stopped working? Consider trying it again later

Tags: , , , |2 Comments

On the surface this doesn't seem like big news.  But grind-it-out studies like these are important.  They help medical oncologists that aren't going to experiment off-label know what to do after a patient relapses. Here's Millennium Pharmaceutical's press release about it: FDA Approves VELCADE® (bortezomib) Retreatment in Patients with Multiple Myeloma  August 8, 2014 CAMBRIDGE,

8 10, 2013

Myeloma News and Views: proteasome inhibitors

Tags: , , , , , , , , |7 Comments

Big news in the myeloma world last week.  Onyx, the company that developed and manufactures the newly FDA approved proteasome inhibitor, Kyprolis (carfilzomib), was purchased by Amgen for a whopping 9.7 billion dollars. If you would like details, I ran a press release about it on our sister site, MyelomaNews.com, October 1st: http://www.myelomanews.com/2013/10/looks-like-proposed-sale-of-onyx-to.html I wrote

3 09, 2013

September is Blood Cancer Awareness Month

Tags: , , , , , , , , |2 Comments

March is Multiple Myeloma Awareness Month.  Do we really need another?  Read this and you tell me! As I greeted support group members arriving before last month's meeting, an older couple that I didn't recognize introduced themselves and headed inside.  "We saw the announcement in the paper." The woman proudly announced loudly. "Are you the

11 08, 2013

EU approves pomalidomide and broader use of Velcade

Tags: , , , , , , , |8 Comments

Europe's Regulatory Commission (EC) has been busy lately.  Sort of like our FDA, the EC approved a broader use of Velcade, then gave the green light for use of Pomalyst in relapsed patients: European Commission Approves VELCADE® As A Frontline Induction Therapy Before Stem Cell Transplantation   Decision could significantly improve transplant outcomes for patients

27 03, 2013

If not Velcade, what next? How about oprozomib?

Tags: , , , , , , , , |9 Comments

I was happy to delay Monday's ongoing conversation a day in honor of myeloma hero, Elijah Alexander.  Let's jump-start things today using Dr. Alsina's own words:  “Now would be a good time to do this.”  She said.  “Your myeloma is stable.  I would do it now.” She was referring to my queries about re-visiting the

25 02, 2013

Patient Snapshot: 21 year survivor, Jim Bond (Part One)

Tags: , , , , , |17 Comments

I first heard Jim Bond's myeloma story four years ago.  I met Jim and his wonderful wife, Kathleen, in Cambridge, Massachusetts.  We had volunteered to help Millennium Pharmaceuticals start a patient advisory board.  As we got to know each other in-between meetings, I learned that Jim was a sixteen year survivor, from Shaker Heights, Ohio,